Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
PARP Inhibitor Shows Promise in Advanced Melanoma Treatment
July 2025
The study highlights how HR pathway alterations, which affect roughly a fifth to a third of melanomas, may offer an opportunity for targeted treatment.
Read more
28 Feb 2025
Maternal Probiotics May Lower Infant Eczema Risk
Findings suggest that probiotics’ ability to reduce the risk of atopic eczema may not depend on significant changes in gut microbiota.
26 Feb 2025
New Evidence Supports Tildrakizumab for Scalp Psoriasis
Patients initially receiving placebo experienced notable improvement after switching to tildrakizumab.
24 Feb 2025
New Study Uncovers Key Mechanisms in Psoriasis
Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.
22 Feb 2025
A New Way to Improve Melanoma Immunotherapy
Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.
20 Feb 2025
Which Treatment for Basal Cell Carcinoma is More Effective?
After five years, the probability of remaining free from treatment failure was 77.8% for patients who underwent superficial curettage.
18 Feb 2025
AI-Powered Sensor Helps Reduce Nocturnal Scratching
While numerous pharmacological treatments for atopic dermatitis exist, there is a scarcity of effective nonpharmacological interventions.
16 Feb 2025
New Approach Lowers Pemphigus Relapse Risk with Additional Rituximab
A targeted rituximab infusion at 6 months, based on relapse predictors, significantly reduced pemphigus recurrence at one year.
14 Feb 2025
Neoadjuvant T-VEC Shows Promise for Difficult-to-Treat Basal Cell Carcinoma
Neoadjuvant T-VEC achieves resectability in 50% of difficult-to-treat BCC cases, improving outcomes without extensive reconstructive surgery.
Loading posts...
« Previous
1
…
5
6
7
8
9
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View